NCT07127185View on ClinicalTrials.gov

Individualized Precision Therapy With Ceftobiprole Guided by PK/PD in Geriatric Populations

Not yet recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

September 12, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions

Ceftobiprole

Interventions

DIAGNOSTIC_TEST

LS/MS

Quantitative determination of ceftobiprole concentrations in plasma and urine was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

All Listed Sponsors

lead

Chinese PLA General Hospital

OTHER

NCT07127185 - Individualized Precision Therapy With Ceftobiprole Guided by PK/PD in Geriatric Populations | Biotech Hunter | Biotech Hunter